Advertisement
Advertisement
U.S. markets open in 5 hours 46 minutes
Advertisement
Advertisement
Advertisement
Advertisement

AlloVir, Inc. (ALVR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.47-0.78 (-4.27%)
At close: 04:00PM EST
17.47 0.00 (0.00%)
After hours: 04:02PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close18.25
Open18.63
Bid0.00 x 900
Ask0.00 x 1200
Day's Range17.39 - 18.66
52 Week Range16.66 - 48.96
Volume337,593
Avg. Volume191,225
Market Cap1.138B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.23
Earnings DateFeb 09, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est44.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALVR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AlloVir, Inc.
    Daily – Vickers Top Buyers & Sellers for 02/05/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • Benzinga

    Allovir Insider Sold Over $465K In Company Stock

    Ann Leen, Insider at Allovir (NASDAQ:ALVR), made a large insider sell on November 16, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Leen sold 20,988 shares of Allovir at prices ranging from $21.76 to $23.18. The total transaction amounted to $465,559. Leen still owns a total of 2,316,154 shares of Allovir worth, $49,310,918. Allovir shares are trading down 0.14% at $21.29 at the time of this writing on Wednes

  • Business Wire

    AlloVir to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

    WALTHAM, Mass., November 15, 2021--AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced today that the company will participate in the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference.

  • Benzinga

    Allovir Insider Trades $300K In Company Stock

    Morana Jovanembiricos, Director at Allovir (NASDAQ:ALVR), made a large insider sell on November 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Jovanembiricos sold 12,196 shares of Allovir at prices ranging from $24.79 to $24.80. The total transaction amounted to $302,455. Following the transaction, Jovanembiricos still owns 373,010 shares of the company, worth $9,209,616. Allovir shares are trading up 1.02%

Advertisement
Advertisement